Luisa Chocarro

17PUBLICATIONS
43CO-AUTHORS
Molecular targetsProteins and peptidesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 16, 2026
PD-1/LAG-3 signaling rewires T-cells via MYC inhibition.

|Aug 10, 2024
Fractalkine in Health and Disease.

Claudia Rodriguez, Luisa Chocarro, Miriam Echaide

|Jul 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio

|Jan 10, 2024
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra

|Aug 10, 2023
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Marta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz

|Jun 28, 2023
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio

Pageof 3

Frequent Collaborators

13 joint publications

Ana Isabel Bocanegra

12 joint publications

Hugo Arasanz

11 joint publications

Ester Blanco

8 joint publications

David Escors